Latest News about GILD
Recent news which mentions GILD
From MarketWatch
Is Galapagos Stock a Bad-News Buy Right Now?
February 23, 2021
From Motley Fool
Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment
February 22, 2021
From Benzinga
Your 2 Best Profit Opportunities in 2021
February 20, 2021
From Motley Fool
Big Tech is swallowing the rest of Silicon Valley
February 19, 2021
From MarketWatch
From Benzinga
3 Biotech Stocks to Buy As Things Heat Up for the Sector
February 18, 2021
From InvestorPlace
UN chief joins WHO in slamming rich countries for hogging COVID vaccines
February 18, 2021
From MarketWatch
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
February 17, 2021
From Motley Fool
Here's What Caused Royalty Pharma's Mixed Results in Q4
February 17, 2021
From Motley Fool
10 Biggest Price Target Changes For Thursday
February 11, 2021
From Benzinga
Two-Third Patients Experienced No CRS/Neurologic Events Up To Three Days After Yescarta, New Data From LBCL Study Shows
February 11, 2021
Tickers
GILD
From Benzinga
4 Top COVID Stocks to Buy in February
February 11, 2021
From Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
February 11, 2021
From Motley Fool
Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program
February 10, 2021
From Motley Fool
Galapagos, Gilead Sciences Pull Plug On Ziritaxestat Clinical Trials
February 10, 2021
From Benzinga
3 Best Biotech Stocks to Buy Now
February 10, 2021
From Motley Fool
What Are Pfizer's Prospects in 2021 and Beyond?
February 10, 2021
From Motley Fool
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
February 10, 2021
From Benzinga
From InvestorPlace
Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now
February 09, 2021
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
February 05, 2021
From Benzinga
Gilead Stock Perks Up After COVID-19 Med Brings In $2.8B In 2020 Sales; Boosts Dividend by 4.4%
February 05, 2021
Tickers
GILD
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
A Peek Into The Markets: US Stock Futures Gain; All Eyes On Jobs Data
February 05, 2021
From Benzinga
8 Stocks To Watch For February 5, 2021
February 05, 2021
From Benzinga
Gilead Sciences (GILD) Q4 2020 Earnings Call Transcript
February 05, 2021
Tickers
GILD
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.